CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1670563
Correction: Identification of Prognosis and Therapy Related Intratumoral Microbiome and Immune Signatures in Gastric Cancer
Provisionally accepted
- 1Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- 2First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Incorrect funding In the published article, there was an error in the Funding statement.The funder [Tianjin Key Medical Discipline (Specialty) Construction Project], [TJYXZDXK-009A] to [Peng Jin] was erroneously omitted. The correct Funding statement appears below. FUNDING The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grants from the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A), Introduction of Talents and Doctoral Startup Fund (B2301 and B2320), The China Postdoctoral Science Foundation (2023M742618) and China National Postdoctoral Program for Innovative Talent (BX20240254).
Keywords: gastric cancer, Intratumoral microbiome, Prognostic biomarkers, Therapeutic responses, drug sensitivity, comprehensive analysis
Received: 21 Jul 2025; Accepted: 31 Jul 2025.
Copyright: © 2025 Jin, Ji, Bai, Su, Ke, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Bin Wang, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.